We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 23 februari 2017

Gene Therapy - Table of Contents alert Volume 24 Issue 2

If you are unable to see the message below, click here to view.
Gene Therapy

Advertisement
Make Gene Therapy Affordable

Offering AAV, lenti and adeno vectors for pre-clinical and clinical applications
Proven track record in preclinical and GMP Phase I/II clinical materials used in vaccine, cell & gene therapy applications for 13 years
Perfect for meeting small-scale aseptic filling in our BSL-3 viral production area 

Learn more

TABLE OF CONTENTS

Volume 24, Issue 2 (February 2017)

In this issue
Editorial
News and Commentary
Comment
Original Articles
Short Communication

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

10 Years of Rare Disease Day

R J Yáñez-Muñoz

Gene Ther 2017 24: 67; 10.1038/gt.2017.7

Full Text

News and Commentary

Top

Gene therapy approaches for prevention of retinal degeneration in Usher syndrome

D S Williams, A Chadha, R Hazim and D Gibbs

Gene Ther 2017 24: 68-71; advance online publication, January 5, 2017; 10.1038/gt.2016.81

Full Text

Comment

Top

Do we need marker gene studies in humans to improve clinical AAV gene therapy?

T Weber

Gene Ther 2017 24: 72-73; advance online publication, January 5, 2017; 10.1038/gt.2016.84

Full Text

Original Articles

Top

APOBEC3A intratumoral DNA electroporation in mice

A Kostrzak, V Caval, M Escande, E Pliquet, J Thalmensi, T Bestetti, M Julithe, L Fiette, T Huet, S Wain-Hobson and P Langlade-Demoyen

Gene Ther 2017 24: 74-83; advance online publication, November 18, 2016; 10.1038/gt.2016.77

Abstract | Full Text

Conditional control of suicide gene expression in tumor cells with theophylline-responsive ribozyme

Y Zhang, J Wang, H Cheng, Y Sun, M Liu, Z Wu and R Pei

Gene Ther 2017 24: 84-91; advance online publication, November 22, 2016; 10.1038/gt.2016.78

Abstract | Full Text

Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment OPEN

E Eriksson, R Moreno, I Milenova, L Liljenfeldt, L C Dieterich, L Christiansson, H Karlsson, G Ullenhag, S M Mangsbo, A Dimberg, R Alemany and A Loskog

Gene Ther 2017 24: 92-103; advance online publication, December 1, 2016; 10.1038/gt.2016.80

Abstract | Full Text

Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice

D Shin, G Lee, S Lee, S Park, K-H Jung, J H Lee, J M Lee, J-Y Kim, J Cho and H Bae

Gene Ther 2017 24: 104-112; advance online publication, December 20, 2016; 10.1038/gt.2016.86

Abstract | Full Text

Short Communication

Top

Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles

D Sharma, R Al-Khalidi, S Edgar, Q An, Y Wang, C Young, D Nowis and D C Gorecki

Gene Ther 2017 24: 113-119; advance online publication, December 22, 2016; 10.1038/gt.2016.82

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group